Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Malingré

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Investigational New Drugs|June 8, 2001
Oral delivery of taxanesM M Malingré, J H Beijnen, J H Schellens
The Annals of Pharmacotherapy|August 6, 2000
Cyclosporine-induced anaphylaxisR A Kuiper, M M Malingré, J H Beijnen, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2007
[Sympathomimetic syndrome caused by autointoxication with methylphenidate]L F D van Vulpen, M M Malingré, R Lange, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Pharmacokinetics of oral cyclosporin A when co-administered to enhance the absorption of orally administered docetaxelM M Malingré, W W Ten Bokkel Huinink, M Mackay, et al.
Anti-Cancer Drugs|August 7, 2001
Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxelM M Malingré, W W Ten Bokkel Huinink, K Duchin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
Modulation of oral bioavailability of anticancer drugs: from mouse to manJ H Schellens, M M Malingré, C M Kruijtzer, et al.
Anti-Cancer Drugs|January 6, 2001
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administrationM M Malingré, J H Schellens, O van Tellingen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxelM M Malingré, D J Richel, J H Beijnen, et al.
British Journal of Cancer|January 5, 2001
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patientsM M Malingré, J H Beijnen, H Rosing, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin AM M Malingré, J H Beijnen, H Rosing, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Investigational New Drugs|June 8, 2001
Oral delivery of taxanesM M Malingré, J H Beijnen, J H Schellens
The Annals of Pharmacotherapy|August 6, 2000
Cyclosporine-induced anaphylaxisR A Kuiper, M M Malingré, J H Beijnen, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2007
[Sympathomimetic syndrome caused by autointoxication with methylphenidate]L F D van Vulpen, M M Malingré, R Lange, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Pharmacokinetics of oral cyclosporin A when co-administered to enhance the absorption of orally administered docetaxelM M Malingré, W W Ten Bokkel Huinink, M Mackay, et al.
Anti-Cancer Drugs|August 7, 2001
Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxelM M Malingré, W W Ten Bokkel Huinink, K Duchin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
Modulation of oral bioavailability of anticancer drugs: from mouse to manJ H Schellens, M M Malingré, C M Kruijtzer, et al.
Anti-Cancer Drugs|January 6, 2001
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administrationM M Malingré, J H Schellens, O van Tellingen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxelM M Malingré, D J Richel, J H Beijnen, et al.
British Journal of Cancer|January 5, 2001
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patientsM M Malingré, J H Beijnen, H Rosing, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin AM M Malingré, J H Beijnen, H Rosing, et al.
Pageof 2